About Paul Kleutghen

Articles by Paul Kleutghen

Antibody-Drug Conjugates and Multiple Myeloma
May 04, 2018
40 genes que pueden alterarse en etapas tempranas del mieloma múltiple
Apr 23, 2018
Armored CAR-T Cells
Mar 12, 2018
$Clinical Trial: Seattle Genetics’ SGN-CD48A Phase I Study for Patients with Relapsed/Refractory Myeloma image$

Clinical Trial: Seattle Genetics’ SGN-CD48A Phase I Study for Patients with Relapsed/Refractory Myeloma
Mar 08, 2018
Long-Term Follow-Up of MGUS Patients
Feb 27, 2018
New Test for Daratumumab (Darzalex) Patients Helps With M-Protein Accuracy
Feb 02, 2018
ASH 2017: Quick ‘Do-It-Yourself’ M-Spike Calculation, the Gamma Gap
Nov 17, 2017
$Guidance for use of Pomalidomide in Relapsed/Refractory Myeloma Patients on Dialysis image$

Guidance for use of Pomalidomide in Relapsed/Refractory Myeloma Patients on Dialysis
Nov 17, 2017
Repurposing an "old" drug for Multiple Myeloma Treatment
Oct 18, 2017
Generic Drugs for Multiple Myeloma: Biosimilars
Jun 27, 2017
Medicare and the Cost of Multiple Myeloma Drugs
Jun 14, 2017
Relapse of Multiple Myeloma: What Happens Next?
May 20, 2017
Myeloma 101: Vaccinations After Myeloma Stem Cell Transplant
May 08, 2017
An Algorithm to Predict GvHD Post Allogeneic Stem Cell Transplants
May 02, 2017
All you ever wanted to know about Immunomodulators (IMiDs) for Multiple Myeloma
Apr 15, 2017
Peripheral Neuropathy and Multiple Myeloma: Not Just Feet and Hands
Feb 15, 2017
Skip the Bone Marrow Biopsy, Single Cell Blood Analysis for Myeloma is Coming Soon
Nov 21, 2016
Hedgehogs, Bortezomib Resistance and Minimal Residual Disease
Oct 31, 2016
Beta Blockers May Improve Survival Outcomes in Patients with Multiple Myeloma
Oct 26, 2016
The Power of Poop: One Strange (But Promising) Method to Avoid Acute Graft vs. Host after a Myeloma Allo Transplant
Oct 18, 2016
Living With
Aug 10, 2016